NCT01333397 - Safety and Efficacy Study of Dysport RU and Glabellar Lines | Biotech Hunter

Enrollment

176

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions

Glabellar Frown Lines

Interventions

BIOLOGICAL

Botulinum toxin type A

I.M. (in the muscle) injection on day 1 (single treatment cycle)

BIOLOGICAL

Botulinum toxin type A

I.M. on day 1 (single treatment cycle)

DRUG

Placebo

I.M. on day 1 (single treatment cycle)

Trial Locations (8)

Private practice, Bordeaux

Private practice, Cannes

Private practice, Juan-les-Pins

Private practice, Paris

Charité hospital, Berlin

Private clinic, Dresden

Private clinic, Munich

Private clinic, Starnberg